EU: Approval given for pancreatic cancer treatment

The European Commission has authorized the marketing of daraxonrasib, a molecule presented as promising for patients with this disease.

Published 1h2 sources✓ ConfirmedImportant
Lire en français
≈ 16s

The fact

Its availability in France is not expected for several months, according to available information.

2 sources — click a link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
Follow topic →
Auto-synthesis from 2 media sources · identified on November 17, 2026
← Back to home
Discover

Read more

All sante →